NCT05618795

Brief Summary

the most commonly used protocol in the management of TMJ ankylosis is Kabans protocol in which 1.5 to 2 cm aggressive resection of bone is recommended which may lead to gap between cranial base and condyle of mandible.1 However, there are certain disadvantages associated with aggressive gap arthroplasty such as pseudo articulation with shortening of the mandibular ramus, premature occlusion on the affected side with a contralateral open bite in unilateral cases,2 in bilateral cases gagging of the posterior teeth and anterior open bite.3 Few studies in the literature available agreed that minimum gap arthroplasty i.e. 5 to 8 mm of gap is sufficient for TMJ movements in all planes and recurrence of ankylosis is likely to be prevented by interposed material (graft)4 .So, a randomized control study to compare outcomes of minimal gap arthroplasty with aggressive gap arthroplasty for management of TMJ ankylosis is planned.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
12

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

November 8, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 16, 2022

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2024

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2024

Completed
Last Updated

November 16, 2022

Status Verified

November 1, 2022

Enrollment Period

1.5 years

First QC Date

November 8, 2022

Last Update Submit

November 8, 2022

Conditions

Keywords

Gap Arthoplasty

Outcome Measures

Primary Outcomes (5)

  • mouth opening

    maximal interincisal distance on opening mouth widely.

    T0- preoperatively

  • mouth opening

    maximal interincisal distance on opening mouth widely.

    T1- 24hr after surgical intervention

  • mouth opening

    maximal interincisal distance on opening mouth widely.

    T2- 1 month after surgical intervention

  • mouth opening

    maximal interincisal distance on opening mouth widely.

    T3- 3 month after surgical intervention

  • mouth opening

    maximal interincisal distance on opening mouth widely.

    T4- 6 month after surgical intervention

Secondary Outcomes (15)

  • Protrusive movement

    T0- preoperatively

  • Protrusive movement

    T1- 24hr after surgical intervention

  • Protrusive movement

    T2- 1 month after surgical intervention

  • Protrusive movement

    T3- 3 month after surgical intervention

  • Protrusive movement

    T4- 6 month after surgical intervention

  • +10 more secondary outcomes

Study Arms (2)

aggresive gap arthoplasty

OTHER

control group- aggressive gap arthroplasty(15 to 20 mm) for management of TMJ ankyosis

Other: minimal gap arthoplasty v/s aggressive gap arthoplasty

minimal gap arthoplasty

ACTIVE COMPARATOR

experimental group-minimal gap arthroplasty(5 to 8mm) for management of TMJ ankylosis

Other: minimal gap arthoplasty v/s aggressive gap arthoplasty

Interventions

Comparative evaluation of aggressive gap arthroplasty with minimal gap arthroplasty in the management of TMJ ankylosis

aggresive gap arthoplastyminimal gap arthoplasty

Eligibility Criteria

Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Medically healthy adult(ASA Classification I-II)
  • Any age group
  • Sawhneys classification type IV
  • Unilateral ankylosis
  • Written informed consent

You may not qualify if:

  • Any syndromic patient
  • Recurrence cases
  • Sawhneys classification type I,II,III

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pgids

Rohtak, Haryana, 124001, India

RECRUITING

Central Study Contacts

Dr. Amrish Bhogal, MDS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 8, 2022

First Posted

November 16, 2022

Study Start

September 1, 2022

Primary Completion

March 1, 2024

Study Completion

September 30, 2024

Last Updated

November 16, 2022

Record last verified: 2022-11

Data Sharing

IPD Sharing
Will not share

Locations